Year: 1960
Type: article
Abstract: In this paper the trivial names of the steroids have been used: cortisol (1 lp,17a,21-trihydroxy-4-pregnene-3,20-dione); cortisone (17a,21-dihydroxy-4-pregnene-3,-11,20-trione); corticosterone (11f,21-dihydroxy-4-pregnene-3,20-dione); tetrahydrocortisone (3a,17a,21-trihydroxy-pregnane-11,20-dione); tetrahydrocortisol (3a,11X8,- 17a,21 -tetrahydroxy-pregnane,20-one); tetrahydrocorti- costerone (3a,11p8,21-trihydroxy-pregnane-20-one); 9a- fluorocortisol (9ca-fluoro-11#,17a,21 -trihydroxy-4-preg- nene-3,20-dione); A1-9a-fluorocortisol (9a-fluoro-1 l,,17a,- MATERIALS AND METHODSSeventeen normal subj ects, one bilaterally adrenalectomized subject, and patients with cirrhosis, myxedema, and thyrotoxicosis were studied.Corticosterone was prepared for intravenous adminis- tration by dissolving 50, 100 or 200 mg of the crystalline steroid in 10 to 15 ml ethanol, which was added to 300 ml sterile 5 per cent dextrose in water.The solution was infused over a period of 10 to 20 minutes.The orally administered corticosterone was suspended in saline or given in a gelatin capsule.Corticosterone-4-C"4 (0.004 ,uc per ,g) was administered intravenously in trace quantities (100 to 400 ,ug) in a small volume of 5 per cent ethanol in sterile distilled water over a period
DOI: 10.1172/jci104091
Authors: Ralph E. Peterson, Charles E. Pierce
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2043322496
